A detailed history of Birch Hill Investment Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Birch Hill Investment Advisors LLC holds 27,914 shares of ABBV stock, worth $4.94 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
27,914
Previous 27,914 -0.0%
Holding current value
$4.94 Million
Previous $4.79 Million 15.15%
% of portfolio
0.27%
Previous 0.24%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $3,095 - $3,615
-20 Reduced 0.07%
27,914 $4.79 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $3,036 - $3,459
-19 Reduced 0.07%
27,934 $5.09 Million
Q4 2023

Jan 29, 2024

SELL
$137.6 - $154.97 $32,611 - $36,727
-237 Reduced 0.84%
27,953 $4.33 Million
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $1,736 - $2,010
13 Added 0.05%
28,190 $4.2 Million
Q2 2023

Jul 20, 2023

BUY
$132.51 - $164.9 $16,431 - $20,447
124 Added 0.44%
28,177 $3.8 Million
Q1 2023

Apr 14, 2023

SELL
$144.61 - $166.54 $16,485 - $18,985
-114 Reduced 0.4%
28,053 $4.47 Million
Q4 2022

Jan 31, 2023

SELL
$138.31 - $165.87 $44,259 - $53,078
-320 Reduced 1.12%
28,167 $4.55 Million
Q3 2022

Oct 19, 2022

SELL
$134.21 - $153.93 $402 - $461
-3 Reduced 0.01%
28,487 $3.82 Million
Q2 2022

Jul 13, 2022

SELL
$137.62 - $174.96 $41,286 - $52,488
-300 Reduced 1.04%
28,490 $4.36 Million
Q1 2022

Apr 08, 2022

SELL
$131.98 - $163.75 $6,598 - $8,187
-50 Reduced 0.17%
28,790 $4.67 Million
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $1,504 - $1,903
14 Added 0.05%
28,840 $3.91 Million
Q2 2021

Jul 22, 2021

BUY
$105.21 - $117.21 $3,787 - $4,219
36 Added 0.13%
28,826 $3.25 Million
Q1 2021

Apr 26, 2021

SELL
$102.3 - $112.62 $23,017 - $25,339
-225 Reduced 0.78%
28,790 $3.12 Million
Q3 2020

Oct 22, 2020

BUY
$85.91 - $100.83 $49,398 - $57,977
575 Added 2.02%
29,015 $2.54 Million
Q4 2019

Jan 17, 2020

SELL
$72.13 - $90.25 $2.05 Million - $2.57 Million
-28,440 Closed
0 $0
Q3 2019

Oct 16, 2019

SELL
$62.98 - $75.72 $3,904 - $4,694
-62 Reduced 0.22%
28,440 $2.15 Million
Q2 2019

Jul 22, 2019

SELL
$65.7 - $83.98 $4,073 - $5,206
-62 Reduced 0.22%
28,502 $2.07 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $3,085 - $3,631
-40 Reduced 0.14%
28,564 $2.3 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $20,716 - $23,029
233 Added 0.82%
28,604 $2.71 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $13,467 - $15,934
-150 Reduced 0.53%
28,371 $2.63 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $68,087 - $91,175
740 Added 2.66%
28,521 $2.7 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $122,697 - $134,547
-1,370 Reduced 4.7%
27,781 $2.69 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $69 - $89
-1 Reduced -0.0%
29,151 $2.59 Million
Q2 2017

Aug 11, 2017

BUY
N/A
29,152
29,152 $2.11 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Birch Hill Investment Advisors LLC Portfolio

Follow Birch Hill Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birch Hill Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Birch Hill Investment Advisors LLC with notifications on news.